CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project develops a point-of-care biosensing technology that significantly improves the detection of HIV through a highly sensitive lateral flow immunoassay. Utilizing innovative nanoparticles, the device aims to facilitate earlier diagnosis and treatment in low-resource settings.
Point-of-care biosensing technologies often suffer from low sensitivity, specificity, affordability and simplicity.
Within ""Nanozymes POC"" we are exploiting a lateral flow immunoassay point-of-care technology supported from the ERC award ""Naturale CG"".
Our paper-based point-of-care device comprises a lateral flow immunosorbent assay showing a sensitivity of 100pg/mL p24 detection and a 100-fold improvement in sensitivity following a catalytic development step involving platinum core-shell na…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
